Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes

NCT01334229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

Laval University

Collaborators

[object Object]